
About ANDE
ANDE is a Healthcare company based in Waltham (United States) founded in 2000 by Richard Selden. Rapid DNA systems are provided for forensic identification and diagnostics. It operates on a Professional Services model. ANDE has raised $131.3 million across 11 funding rounds from investors including HHS and Ojp. The company has 49 employees. ANDE offers products and services including Rapid DNA for Human Identification, Rapid DNA for Energy, and Rapid DNA for Biosurveillance. Its focus areas include Technology, Biotechnology and DNA Analysis. Its legal entity is ANDE Corporation. Its competitors include DDC Paternity Tests, Applied DNA Sciences and Othram; 1 of its 3 listed competitors has raised funding.
Company details
ANDE is engaged in delivering Rapid DNA technology for diverse applications including human identification, energy, and biosurveillance. Solutions are designed to be mobile and rugged, enabling integration into daily operations across different sectors. The technology is validated by over 50 scientific and public safety organizations globally. Emergency response support is also offered through the ANDE Fly Team for critical cases and mass casualty incidents.
- Total Equity Funding$131.3M (USD)
in 11 rounds
- Latest Funding Round$19.75M (USD), Series C
Apr 2020
- InvestorsHHS
& 1 more
- Employee Count49
Products & Services of ANDE
ANDE offers a comprehensive portfolio of products and services, including Rapid DNA for Human Identification, Rapid DNA for Energy, and Rapid DNA for Biosurveillance.
Rapid DNA technology is used for human identification.
DNA technology is applied in energy sector solutions.
DNA technology is utilized for biosurveillance monitoring purposes.
Funding Insights of ANDE
ANDE has successfully raised a total of $131.3M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $19.75 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $131.3M
- Total Rounds 11
- Last Round Series C β $19.75M
- First Round $498,563
(Sep 2008)
- Investors Count 2
Latest 10 of 11 funding rounds of ANDE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $19.75M | Series C | β | β | β |
| Jun 2019 | $31.01M | Series C | β | β | β |
| Nov 2018 | $47.63M | Series C | β | β | β |
| Jan 2018 | $16M | Series B | β | β | β |
| Jun 2017 | $16.91M | Series B | β | β | β |
| Jul 2011 | $594,001 | Grant | β | β | |
| Aug 2009 | $4.82M | Grant | β | β | |
| Jul 2009 | $3.88M | Grant | β | β | |
| Jul 2009 | $880,045 | Grant | β | β | |
| Sep 2008 | $494,319 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in ANDE
ANDE has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Ojp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Federal justice system funding, training, and resources are provided. | ojp.gov |
Investor details for ANDE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ANDE
17 people are tracked at ANDE (11 in leadership, 6 in team); the tracked headcount is 49.
| Name | Role | Group |
|---|---|---|
Richard Selden | Founder & Chairman | Leadership |
Melissa Schwandt | Director of Field Science & Customer Support | Leadership |
Eric Fang | President, ANDE China | Leadership |
Steve.Lowe Lowe | Chief Commercial Officer | Leadership |
George Heinrichs | Chief Executive Officer | Leadership |
Julie French | Senior Vice President, Global Scientific Support | Leadership |
Steve Bohn | Chief Financial Officer | Leadership |
Eddy Dolan | Managing Director Latin America | Leadership |
Sandra Lea Otsuki | VP Of People | Leadership |
Troy Deppey | Vice President Of Global Operations | Leadership |
Brian B. | Vice President Global Markets | Leadership |
Lewis Shaw | Field Application Scientist | Team |
Kristen D. | Field Application Scientist | Team |
Chad Gemmen | Field Service Engineer | Team |
James Y. | Global Senior Support Engineer | Team |
Todd Simon | Corporate Controller | Team |
Grace Whittemore | Staff Accountant | Team |
Complete people profiles for ANDE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ANDE
3 dated milestones of ANDE across 20 years, from founding to its latest funding, stage changes and deals.
- Founded ANDE is founded.
- Funding First funding round of $499K.
- Funding Latest funding round, Series C, of $19.8M.
Competitors of ANDE
ANDE has 3 listed competitors in our database, 1 of them funded. They include DDC Paternity Tests, Applied DNA Sciences and Othram.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dnacenter.com | 1995 | Fairfield, United States | DNA tests and personalized diagnostics are provided for various specialties. | |||
| adnas.com | 1983 | Stony Brook, United States | 55 | Botanical-DNA-based security and authentication solutions are developed. | ||
| othram.com | 2018 | Houston, United States | $33.16M | 22 | Genomic services are provided for forensic investigations and research. |
Detailed competitors of ANDE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ANDE
The website of ANDE (ande.com) receives about 5.1K visits a month.
- Monthly visits5.1K
▼ 17.2% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ANDE (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ande
Complete news archive for ANDE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ANDE
ANDE was founded in 2000 and raised its 1st funding round 8 years after it was founded.
ANDE is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
ANDE is a funded company, having raised a total of $131.3M across 11 funding rounds to date. The company's 1st funding round was a Grant of $494.32K, raised on Sep 2008.
ANDE has 49 employees.
ANDE is engaged in delivering Rapid DNA technology for diverse applications including human identification, energy, and biosurveillance. Solutions are designed to be mobile and rugged, enabling integration into daily operations across different sectors. The technology is validated by over 50 scientific and public safety organizations globally. Emergency response support is also offered through the ANDE Fly Team for critical cases and mass casualty incidents.
ANDE's top competitors include DDC Paternity Tests, Applied DNA Sciences and Othram.
ANDE offers Rapid DNA for Human Identification, Rapid DNA for Energy, and Rapid DNA for Biosurveillance.
ANDE operates through Ande Corporation.
